Rhythm Pharmaceuticals (RYTM) Short Interest Ratio & Short Volume → [URGENT] DO NOT Touch These AI Stocks! (From Weiss Ratings) (Ad) Free RYTM Stock Alerts $37.96 -1.21 (-3.09%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Rhythm Pharmaceuticals Short Interest DataCurrent Short Volume10,590,000 sharesPrevious Short Volume10,200,000 sharesChange Vs. Previous Month+3.82%Dollar Volume Sold Short$421.06 millionShort Interest Ratio / Days to Cover17.5Last Record DateApril 30, 2024Outstanding Shares60,970,000 sharesPercentage of Shares Shorted17.37%Today's Trading Volume750,715 sharesAverage Trading Volume567,333 sharesToday's Volume Vs. Average132% Short Selling Rhythm Pharmaceuticals ? Sign up to receive the latest short interest report for Rhythm Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRYTM Short Interest Over TimeRYTM Days to Cover Over TimeRYTM Percentage of Float Shorted Over Time Ad Behind the MarketsForget Bitcoin: This $8 Stock Is the Next Big Thing4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Rhythm Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202410,590,000 shares $421.06 million +3.8%N/A17.5 $39.76 4/15/202410,200,000 shares $408.92 million +4.7%N/A17.1 $40.09 3/31/20249,740,000 shares $422.03 million +5.9%N/A15.4 $43.33 3/15/20249,200,000 shares $368 million +2.2%N/A13.7 $40.00 2/29/20249,000,000 shares $390.78 million +2.7%N/A12.3 $43.42 2/15/20248,760,000 shares $442.12 million -1.1%N/A11.7 $50.47 Get the Latest News and Ratings for RYTM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rhythm Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/20248,860,000 shares $390.81 million +4.9%N/A11.6 $44.11 1/15/20248,450,000 shares $343.75 million +3.8%N/A11.7 $40.68 12/31/20238,140,000 shares $374.20 million -5.8%N/A11.5 $45.97 12/15/20238,640,000 shares $407.81 million -6.6%N/A13.2 $47.20 11/30/20239,250,000 shares $309.23 million -1.7%N/A15.2 $33.43 11/15/20239,410,000 shares $301.78 million -19.2%N/A16.5 $32.07 10/31/202311,650,000 shares $269.23 million -1.2%23.2%19.9 $23.11 10/15/202311,790,000 shares $294.51 million +16.9%23.6%17.3 $24.98 9/30/202310,090,000 shares $231.31 million -15.8%20.2%14.6 $22.93 9/15/202311,980,000 shares $299.02 million +12.5%24.0%16.8 $24.96 8/31/202310,650,000 shares $277.01 million -2.8%21.3%13.3 $26.01 8/15/202310,960,000 shares $287.04 million -11.7%22.0%13.7 $26.19 7/31/202312,410,000 shares $221.39 million +8.1%N/A16.1 $17.84 7/15/202311,480,000 shares $182.88 million +4.4%N/A16.2 $15.93 6/30/202311,000,000 shares $181.39 million +10.8%N/A15.4 $16.49 6/15/20239,930,000 shares $181.52 million +2.5%N/A13.6 $18.28 5/31/20239,690,000 shares $161.44 million +8.0%N/A15.2 $16.66 5/15/20238,970,000 shares $151.50 million +6.0%N/A12.7 $16.89 4/30/20238,460,000 shares $170.64 million +3.6%N/A12.7 $20.17 4/15/20238,170,000 shares $158.50 million +1.6%N/A13 $19.40 3/31/20238,040,000 shares $143.43 million +8.9%N/A12.5 $17.84 3/15/20237,380,000 shares $134.54 million -9.0%15.0%12.1 $18.23 2/28/20238,110,000 shares $197.15 million -0.4%16.6%13.2 $24.31 2/15/20238,140,000 shares $214.57 million +5.2%16.8%15 $26.36 1/31/20237,740,000 shares $211.69 million -2.4%16.0%12.9 $27.35 1/15/20237,930,000 shares $247.81 million +1.2%16.4%12.7 $31.25 12/30/20227,840,000 shares $228.30 million -3.1%16.2%12.5 $29.12 12/15/20228,090,000 shares $228.95 million +2.8%16.7%11.7 $28.30 11/30/20227,870,000 shares $210.68 million -6.8%16.3%7.9 $26.77 11/15/20228,440,000 shares $222.14 million +0.5%17.4%8 $26.32 10/31/20228,400,000 shares $211.43 million +10.2%17.4%7.4 $25.17 10/15/20227,620,000 shares $169.24 million -0.1%15.8%5.6 $22.21 9/30/20227,630,000 shares $186.94 million +26.5%16.1%3.1 $24.50 9/15/20226,030,000 shares $140.56 million +3.8%12.7%2.4 $23.31Forget Bitcoin: This $8 Stock Is the Next Big Thing (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> RYTM Short Interest - Frequently Asked Questions What is Rhythm Pharmaceuticals' current short interest? Short interest is the volume of Rhythm Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 10,590,000 shares of RYTM short. Learn More on Rhythm Pharmaceuticals' current short interest. What is a good short interest ratio for Rhythm Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RYTM shares currently have a short interest ratio of 18.0. Learn More on Rhythm Pharmaceuticals's short interest ratio. Which institutional investors are shorting Rhythm Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Rhythm Pharmaceuticals: Torno Capital LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Rhythm Pharmaceuticals' short interest increasing or decreasing? Rhythm Pharmaceuticals saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 10,590,000 shares, an increase of 3.8% from the previous total of 10,200,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Rhythm Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Rhythm Pharmaceuticals: Dyne Therapeutics, Inc. (18.91%), ACADIA Pharmaceuticals Inc. (7.28%), Janux Therapeutics, Inc. (9.55%), Indivior PLC (0.14%), PTC Therapeutics, Inc. (12.95%), MoonLake Immunotherapeutics (14.00%), Bausch Health Companies Inc. (5.73%), Merus (5.76%), Maravai LifeSciences Holdings, Inc. (6.66%), Vera Therapeutics, Inc. (16.61%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Rhythm Pharmaceuticals stock? Short selling RYTM is an investing strategy that aims to generate trading profit from Rhythm Pharmaceuticals as its price is falling. RYTM shares are trading down $1.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Rhythm Pharmaceuticals? A short squeeze for Rhythm Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RYTM, which in turn drives the price of the stock up even further. How often is Rhythm Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RYTM, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: DYN Short Interest ACAD Short Interest JANX Short Interest INDV Short Interest PTCT Short Interest MLTX Short Interest BHC Short Interest MRUS Short Interest MRVI Short Interest VERA Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RYTM) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBill Gates is all about this tiny $2 stockTimothy SykesCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the Markets[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsBuy this small stock before coming AI Tidal WaveChaikin AnalyticsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHow Biden has already won 2024Porter & Company